The Duchenne Diagnosis: What Does it Mean?

Transcription

The Duchenne Diagnosis: What Does it Mean?
The Duchenne Diagnosis:
What Does it Mean?
Kevin M. Flanigan, MD
University of Utah
Outline (I)
• A very little bit of:
– History
– Clinical overview
– Biology
• Muscle
• The dystrophin protein
• The DMD gene
• Terms that are thrown around a lot (and that you will hear a lot over the coming days)
• Guillaime Duchenne
de Boulogne (Paris)
– Pseudohypertophic
paralysis, or myosclerotic
paralysis (1868)
• Edward Meryon
(London), 1851
• Gaetano Conte (Naples), 1836
Roberts, Genome Biology, 2001
The dystrophinopathies:
a spectrum of phenotypes
• Duchenne Muscular Dystrophy
– Onset age 3‐5
– Loss of ambulation before age 12
• “Intermediate Muscular Dystrophy”
– Loss of ambulation age 12‐15
• Becker Muscular Dystrophy
– Loss of ambulation after age 15
Detection of protein using antibodies
Immunofluorescent = = Immunohistochemical
Immunoblot
or
Western blot
N
B
D
N
Dystrophin
(427 kd)
Muscle is ground up, and the protein is:
1. Run out on a gel
2. Transferred to a membrane
3. Visualized using an antibody
Tells us the size
and the amount of the protein
GAPDH
Dystrophin Mutations: The DMD gene
• The DMD gene is huge: – 2.2 million base pairs
– 79 exons and 8 promoters
• Spectrum of genotypes:
– Large deletions (≥ 1 exon) account for ~60% of DMD/BMD patients – ~5% have duplications
– ~15% of boys have premature stop codon mutations
– Frameshifting insertions/deletions, splice site mutations, missense mutations
Reading Frame
THE BIG RED DOG RAN AND SAT
T HEB IGR EDD OGR ANA NDS AT
TH EBI GRE DDO GRA NAN DSA T
Reading Frame
• THE BIG RED DOG RAN AND SAT
Reading Frame
• THE BIG RED DOG RAN AND SAT
• THE BIR EDD OGR ANA NDS AT
Reading Frame
• THE BIG RED DOG RAN AND SAT
• THE BIR EDD OGR ANA NDS AT
• THE DOG RAN AND SAT
Reading Frame
• THE BIG RED DOG RAN AND SAT
• THE BIR EDD OGR ANA NDS AT
= Duchenne (more severe) Muscular Dystrophy
• THE DOG RAN AND SAT
= Becker (less severe) Muscular Dystrophy
Antisense oligonucleotides that induce exon skipping
Exon B
Exon A
THE BIG RED DOG RAN AND SAT
Out‐of‐frame deletion (DMD) pre‐mRNA:
THE BID OGR ANA NDS AT
In‐frame deletion (BMD) mRNA:
THE DOG RAN AND SAT
• Exon skipping aims to turn a Duchenne
mutation into a Becker mutation
• How much benefit will depend upon several factors, including:
– Which exons are skipped
– How much skipping occurs (percentage of the gene transcript)
Outline (II)
• What can one expect from:
–Future therapies/Clinical Trials
• Personal perspective
–Cautions (not hopelessness, but cautions)
–Current therapies
• Clinics/clinical care
• Need for further trials
Genetics isn’t everything
Knowing your son’s mutation is:
– Useful for counseling
– May help with prognosis
– Potentially important for specific therapies
But it isn’t:
– A guaranteed entry into trials
– A guarantee that therapies in trials will work
Trials are trials:
No one knows if the therapies will work
• Mice aren’t humans, and don’t have Duchenne muscular dystrophy
• Caution against having all of your eggs in one basket.
– “Lucky” vs. “unlucky” mutations
– “Should we hold off treatment X until an exon
skipping trial is here?”
– PTC124/nonsense mutations
Things parents need to remember
about trials
• You may get a placebo
• Trials are an enormous investment:
– In time away from school (and work)
– In energy
– In hope
• They may require more effort than you originally expect
• A positive result may not be improvement, but only stabilization
Therapeutic trials can’t substitute for good clinical care
• Good clinical care for DMD:
– Extends life expectancy
– Improves quality of life
– Improves chances of benefiting from new therapies down the road
• Excellent program over the next few days
• Communication with the clinical team is key
There is no single recipe for what is good clinical care
• Caution patients to be wary of any conversation that starts “But you have to…” • Every family is different, and will have to find their own “best way”
– Prednisone vs. deflazacort
– Daily vs other regimens
– Supplements Costs
• Steroids: 35 kg boy
– Prednisone 20 mg 60 tablets + 5 mg 60 tablets = $18
– Deflazacort 30 mg 60 capsules = $100
• Supplements:
– Protandim 30 capsules = $45 ($1.50/day)
– Haelan 951 8 oz bottle = $51 ($25.50/day at 4 oz/day, or $9307/year)
• HGH: (16 y.o.) = $171/day ($62,415/year)
We need more trials
Not only
• Supplements
• Exon skipping
But also:
• Steroid regimens
• Losartan
• Presymptomatic ACE inhibitors
• Human Growth Hormone
• etc.
Not pessimism!
Extraordinary progress has been made:
• Research
– Understanding mechanisms
– Approaching new therapies
• Generating standards of care
• Getting this information to families Acknowledgments
• The boys and young men with DMD and BMD (and their parents) who
– Have allowed me to take part in their care
– Have participated in research studies for the benefit of the whole dystrophinopathy community

Similar documents

Duchenne Muscular Dystrophy Market Treatment, Symptoms, Pipeline Review, H1 2016

Duchenne Muscular Dystrophy Market Treatment, Symptoms, Pipeline Review, H1 2016 Global Markets Direct's, 'Duchenne Muscular Dystrophy - Pipeline Review, H1 2016', provides an overview of the Duchenne Muscular Dystrophy pipeline landscape. Visit Us @ http://www.radiantinsights.com/research/duchenne-muscular-dystrophy-pipeline-review-h1-2016

More information